This week, a baby beams at his father after surgery for congenital cataracts, an ultraprecise cannula delivers drugs into retinal veins and the FDA clears Canon’s automated OCT device.

A novel monotherapy may reduce the risk of relapse for patients with neuromyelitis optica spectrum disorder (NMOSD), according to data presented by Genentech at the 35th Congress of the European Committee for Treatment and Research in Multiple Sclerosis.

This retrospective review describes the clinical outcomes of 75 external dacryocystorhinostomy (DCR) procedures in patients with systemic sarcoidosis.

This cross-sectional study examined the association between genetic risk variants of primary open-angle glaucoma (POAG) and age at the time of diagnosis.

This IRIS Registry-based study assessed the incidence and visual outcomes of acute-onset endophthalmitis after cataract surgery in the United States.

In this study, the authors investigated the prevalence of angle kappa in hyperopic eyes and its effect on the refractive outcomes of excimer laser vision correction.

This week, chimps and bonobos may use eye gaze as social cues, a teenager’s limited diet causes permanent blindness and a Japanese woman is the first to have her cornea repaired using reprogrammed stem cells.

This large prospective case series assess factors relating to explantation of iris-fixated phakic IOLs.

This retrospective case series examined the consequences of interrupted anti-VEGF therapy for diabetic retinopathy (DR).

In this study, investigators described changes in refraction and amblyopia in children undergoing surgery for congenital ptosis.

This study explored whether yellow lens night-driving glasses improve nighttime road visibility and reduce headlight glare from oncoming vehicles.

This review article describes recent advances in the diagnosis, treatment and prevention of herpes zoster, as well as neurological and ophthalmological complications of infection.

The Academy is teaming up with Verana Health to launch Verana Practice Insights, a service that enables physicians to improve patient care with data-driven insights.

This multicenter trial assessed the ability of phacoemulsification with goniosynechialysis to reduce IOP through 1 year.

This week, a begonia graces an exhibit of photographs taken by donor cornea recipients, vehicle exhaust may raise the risk of AMD and a new voice assistant browses the web for people with visual impairment.

In this prospective trial, the authors investigated IOP changes during neurosurgical procedures with opening of the dura mater and loss of cerebrospinal fluid.

Researchers assessed the safety and efficacy of the ranibizumab Port Delivery System (PDS) for neovascular AMD.

This study analyzes the clinical, histologic and molecular genetic profiles of primary orbital melanoma.

Aflibercept (Eylea) will soon be available in a 2-mg sterile prefilled syringe, according to a press release by Regeneron Pharmaceuticals.

This retrospective study offers new understanding to the genetics and evolution of uveal melanoma.

This week, researchers develop an eye-on-a-chip model for dry eye disease, aflibercept sales continue to impress and a new documentary follows 4 artists who have partial or complete blindness.

In this prospective analysis, researchers assessed perfused capillary density (PCD) in diabetic and healthy patients using OCT imaging.

This study compared corneal higher-order aberrations after ultrathin Descemet stripping automated endothelial keratoplasty (DSAEK) versus Descemet membrane endothelial keratoplasty (DMEK).

This week, Pixium’s bionic vision system restores sight to patients with advanced AMD, a brain tumor lingers behind a woman’s red, itchy eyes and Bascom Palmer Eye Institute tops the Best Hospitals for Ophthalmology survey for the 14th year in a row.

Editas Medicine and Allergan are teaming up to conduct the first human trial of a CRISPR gene-editing therapy for inherited blindness.